Mark P Thomas1, Stephen J Mills1, Barry V L Potter2. 1. Department of Pharmacy & Pharmacology, University of Bath, Claverton Down, Bath, BA2 7AY, UK. 2. Department of Pharmacology, University of Oxford, Mansfield Road, Oxford, OX1 3QT, UK. barry.potter@pharm.ox.ac.uk.
Abstract
Cell signaling via inositol phosphates, in particular via the second messenger myo-inositol 1,4,5-trisphosphate, and phosphoinositides comprises a huge field of biology. Of the nine 1,2,3,4,5,6-cyclohexanehexol isomers, myo-inositol is pre-eminent, with "other" inositols (cis-, epi-, allo-, muco-, neo-, L-chiro-, D-chiro-, and scyllo-) and derivatives rarer or thought not to exist in nature. However, neo- and d-chiro-inositol hexakisphosphates were recently revealed in both terrestrial and aquatic ecosystems, thus highlighting the paucity of knowledge of the origins and potential biological functions of such stereoisomers, a prevalent group of environmental organic phosphates, and their parent inositols. Some "other" inositols are medically relevant, for example, scyllo-inositol (neurodegenerative diseases) and d-chiro-inositol (diabetes). It is timely to consider exploration of the roles and applications of the "other" isomers and their derivatives, likely by exploiting techniques now well developed for the myo series.
Cell signaling via inositol phosphates, in particular via the second messenger n class="Chemical">myo-inositol 1,4,5-trisphosphate, and phosphoinositides comprises a huge field of biology. Of the nine 1,2,3,4,5,6-cyclohexanehexol isomers, myo-inositol is pre-eminent, with "other" inositols (cis-, epi-, allo-, muco-, neo-, L-chiro-,D-chiro-, and scyllo-) and derivatives rarer or thought not to exist in nature. However, neo- and d-chiro-inositol hexakisphosphates were recently revealed in both terrestrial and aquatic ecosystems, thus highlighting the paucity of knowledge of the origins and potential biological functions of such stereoisomers, a prevalent group of environmental organic phosphates, and their parent inositols. Some "other" inositols are medically relevant, for example, scyllo-inositol (neurodegenerative diseases) and d-chiro-inositol (diabetes). It is timely to consider exploration of the roles and applications of the "other" isomers and their derivatives, likely by exploiting techniques now well developed for the myo series.
Authors: Gary G Adams; Shahwar Imran; Sheng Wang; Abubaker Mohammad; M Samil Kok; David A Gray; Guy A Channell; Stephen E Harding Journal: Crit Rev Food Sci Nutr Date: 2014 Impact factor: 11.176
Authors: Zhao Ding; Ana M Rossi; Andrew M Riley; Taufiq Rahman; Barry V L Potter; Colin W Taylor Journal: Mol Pharmacol Date: 2010-03-09 Impact factor: 4.436
Authors: Stephen J Mills; Fabrice Vandeput; Melanie N Trusselle; Stephen T Safrany; Christophe Erneux; Barry V L Potter Journal: Chembiochem Date: 2008-07-21 Impact factor: 3.164
Authors: J Larner; L C Huang; C F Schwartz; A S Oswald; T Y Shen; M Kinter; G Z Tang; K Zeller Journal: Biochem Biophys Res Commun Date: 1988-03-30 Impact factor: 3.575
Authors: Nicolás Veiga; Julia Torres; Israel Macho; Kerman Gómez; Himali Y Godage; Andrew M Riley; Barry V L Potter; Gabriel González; Carlos Kremer Journal: Dalton Trans Date: 2013-05-07 Impact factor: 4.390
Authors: Hayley Whitfield; Andrew M Riley; Soulla Diogenous; Himali Y Godage; Barry V L Potter; Charles A Brearley Journal: Plant Soil Date: 2017-06-27 Impact factor: 4.192
Authors: Luciana N Moreira; Josiane F Silva; Grazielle C Silva; Virgínia S Lemos; Steyner F Cortes Journal: Front Pharmacol Date: 2018-05-22 Impact factor: 5.810